KIMS Issues Corrigendum for EGM Notice Regarding Preferential Issue
KIMS has issued a corrigendum to its EGM notice for a preferential issue. The EGM is scheduled for July 9, 2026. The corrigendum clarifies updated debt repayment amounts totaling ₹3,42,79,59,983 and confirms the promoter status of Dr. Abhinay Bollineni, Mr. Adwik Bollineni, and Bharas Ventures LLP.
The corrigendum relates to a preferential issue, which is a form of equity fundraising. It involves clarifications on debt repayment amounts and promoter status, which are material details for investors considering the preferential issue. The EGM date remains the same, indicating ongoing corporate action.
The announcement is a corrigendum to a previous notice, rectifying errors and providing clarifications. While it concerns a preferential issue, it does not introduce new positive or negative financial information but rather corrects and clarifies existing details.
Krishna Institute of Medical Sciences Limited (KIMS) has issued a corrigendum to its Extraordinary General Meeting (EGM) notice, originally disseminated on 17 June 2026. The EGM is scheduled for Thursday, 9 July 2026, at 16:00 IST via Video Conferencing (VC) / Other Audio Visual Means (OAVM).
The corrigendum addresses clarifications requested by the National Stock Exchange (NSE) and rectifies inadvertent typographical errors in the explanatory statement related to Item No. 1 of the EGM Notice, which concerns a proposed preferential issue of equity shares. The NSE had advised the company to provide these clarifications via a corrigendum through its letter dated 3 July 2026.
Specifically, the corrigendum updates the amounts for outstanding debts to be repaid from the preferential issue proceeds. For KIMS Hospital Bengaluru Private Limited's loan from ICICI Bank, the total outstanding amount as of 30 April 2026 is corrected to ₹ 2,27,91,60,879. For Arunodaya Hospitals Private Limited's term loan from Indusind Bank Limited, the corrected outstanding amount is ₹ 69,87,99,104. The total outstanding debt to be repaid is now ₹ 3,42,79,59,983.
Additionally, the corrigendum clarifies the status of proposed allottees. Dr. Abhinay Bollineni and Mr. Adwik Bollineni are confirmed to be Promoters before and after the preferential issue. Bharas Ventures LLP is confirmed to be part of the Promoter Group before and after the preferential issue.
The corrigendum is being circulated electronically to members and is also available on the company's website, the websites of BSE and NSE, and the website of MUFG Intime India Private Limited.
What to do with a filing like this
Krishna Institute of Medical Sciences Limited filed this with the NSE as a statutory disclosure, categorised under egm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Krishna Institute of Medical Sciences Limited. Read the original for the full detail.